Furthermore, GLP-1R/glucagon receptor dual agonists are being investigated for the treatment of NAFLD ( The pathogenesis of non-alcoholic fatty liver disease The first phase of NAFLD is characterized by accumulation of fat in the liver (hepatic steatosis), which may progressively lead to NASH (in 520% of patients) with or without concomitant fibrosis
Currently, dietary modifications, along with agents such as acarbose, diazoxide, and somatostatin analogs, continue to represent the standard management approach despite challenges related to tolerability, adherence, and variable efficacy
That complexity is the starting point for every downstream decision, from column choice to impurity control to identity confirmation, all of which come together in this comprehensive guide to GLP-1 peptide analysis
Of particular concern are new findings linking semaglutide-based medications, including Ozempic, Wegovy, and Rybelsus, to a rare but devastating eye condition
Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA(inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer